Enhanc3D Genomics
Cambridge
About Enhanc3D Genomics
Enhanc3D Genomics is a functional genomics firm that studies the three-dimensional organization of DNA in health and disease. The company's GenLink3D platform helps comprehend the impact of such mutations on distant genes, thereby revealing how they influence disease progression.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: enhanc3dgenomics.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/enhanc3d-genomics-11983 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.